866-997-4948(US-Canada Toll Free)

Global Market Study on Regenerative Therapies: Asia Pacific & Japan to Witness Highest Growth by 2022

Published By :

Persistence Market Research

Published Date : Apr 2016

Category :

Therapeutic Area

No. of Pages : 224 Pages

This Persistence Market Research (PMR) report examines the regenerative therapies market for the period 2016 - 2022. The primary objective of the report is to offer insights into developments in the regenerative therapies market that are significantly helping transform the growth trajectory of global businesses and enterprises associated with the same.

Regenerative therapies entail the application of specific types of cells or cell products for diseased tissues or organs, which ultimately help restore usual tissue and organ function. It also includes the possibility of growing tissues and organs in the laboratory and safely implanting them when the body cannot heal itself.

The regenerative therapies market holds major potential in the near future, which is attributed to the increasing application of these therapies in the treatment of various classes of diseases. The prime factor responsible for the same is the collaborative R&D efforts undertaken by researchers and manufacturers to develop and introduce newer and more efficient therapies. Orthopedic, cardiovascular, and soft tissue repair are the three main application segments in the global regenerative therapies market. Recently, there has been an alarming rise in the incidence rate of these disorders across the globe. Soft tissue repair and skin restoration therapies are currently the most widely adopted regenerative therapies globally.

Surge in government support and funding from various organizations for R&D related to regenerative therapies over the last few years and increasing incidences of chronic diseases are among the major factors driving growth of the global regenerative therapies market currently.

The regenerative therapies market is segmented as follows:

  • Regenerative Therapies Market, by Tissue Type
  • Regenerative Therapies Market, by Application Type
  • Regenerative Therapies Market, by End User
  • Regenerative Therapies Market, by Region

This report covers the global regenerative therapies market performance in terms of revenue contribution from various segments. This section also includes PMRs analysis of the key trends, drivers, restraints and opportunities, which are influencing growth of the global regenerative therapies market currently. Impact analysis of the key growth drivers and restraints is also included in this report to better equip clients with crystal clear decision-making insights.

The regenerative therapies market report begins with an overview of the regenerative therapies procedures, covering the reasons why the patients are increasingly adopting these therapies. This section also underlines factors influencing growth of the regenerative therapies market currently, along with detailed analysis of the key trends, drivers, restraints, opportunities and regulations. Impact analysis of the key regional growth drivers and restraints based on the weighted average model, coupled with key region-specific trends, is included in report to better equip clients with information and hidden insights.

The global regenerative therapies market is segmented based on tissue type into allografts, xenografts, and alloplasts. Based on application type, the market has been segmented into soft tissue repair, cardiovascular, dental, orthopaedic, CNS disease treatment, and others. Based on end user, the market has been segmented into hospitals, ambulatory surgical centers, and educational institutes. A detailed analysis of every segment has been presented in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index and BPS analysis. Among the various tissue types, allografts are expected to emerge as the product of choice both among surgeons and patients worldwide. Xenografts are also expected to gain popularity over the forecast period.

The next section of the report highlights the growth trends in the regenerative therapies market, by region. It provides the market outlook for 20162022 and sets the forecast within the context of the regenerative therapies market. The study discusses the key regional trends contributing to growth of the regenerative therapies market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific and the MEA. North America is expected to emerge as the most dominant and most attractive market over the forecast period.

The above sections by tissue type, by application, by end user, and by region evaluate the present scenario and growth prospects of the regenerative therapies market for the period 2016 - 2022. We have considered 2014 as the base year and provided data for the forecast period.

Detailed company profiles include company-specific long-term and short-term strategies, key offerings, and recent developments by the concerned companies in the regenerative therapies market.

Key competitors in the market include:

  • Acelity L.P. Inc.
  • Mesoblast Ltd.
  • Nuo Therapeutics, Inc. (Cytomedix).
  • Astellas Pharma US, Inc.
  • Organovo Holdings Inc.
  • Orgenesis Inc.
  • Sanofi.
  • Athersys, Inc.
  • Shire Pharmaceuticals Limited.
  • Cytori Therapeutics Inc.
  • Other.

Table of Content

1. Global Regenerative Therapies Market - Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Global Regenerative Therapies Market Overview

4.1. Introduction
4.1.1. Regenerative Therapies Market Definition
4.1.2. Regenerative Therapies Market Taxonomy
4.2. Regenerative Therapies Market Application Overview
4.3. Parent Market Overview
4.4. Regenerative Therapies Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.4.4. Value Chain
4.5. Global Regenerative Therapies Market Forecast, 2015-2021
4.5.1. Market Value Forecast
4.5.2. Y-o-Y Growth Projections
4.5.3. Absolute $ Opportunity
4.6. Regenerative Therapies Market Trends
4.7. Global Regenerative Therapies Market Snapshot (2014)
4.7.1. Market Share, By Application
4.7.2. Market Share, By End User
4.7.3. Market Share, By Product
4.7.4. Market Share, By Region

5. Global Regenerative Therapies Market Analysis, By Tissue Type
5.1. Introduction
5.1.1. Y-o-Y Growth Comparison, By Tissue Type
5.1.2. Market Share & Basis Point (BPS) Analysis, By Tissue Type
5.2. Market Forecast, By Tissue Type
5.2.1. Allograft
5.2.1.1. Absolute $ Opportunity
5.2.1.2. Market Value Forecast, By Region
5.2.2. Xenograft
5.2.2.1. Absolute $ Opportunity
5.2.2.2. Market Value Forecast, By Region
5.2.3. Alloplast
5.2.3.1. Absolute $ Opportunity
5.2.3.2. Market Value Forecast, By Region
5.3. Market Attractiveness Analysis, By Tissue Type
5.4. Prominent Trends

6. Global Regenerative Therapies Market Analysis, By Application
6.1. Introduction
6.1.1. Y-o-Y Growth Comparison, By Application
6.1.2. Market Share & Basis Point (BPS) Analysis, By Application
6.2. Market Forecast, By Application
6.2.1. Soft Tissue Repair
6.2.1.1. Absolute $ Opportunity
6.2.1.2. Market Value Forecast, By Region
6.2.2. Cardiovascular
6.2.2.1. Absolute $ Opportunity
6.2.2.2. Market Value Forecast, By Region
6.2.3. Dental
6.2.3.1. Absolute $ Opportunity
6.2.3.2. Market Value Forecast, By Region
6.2.4. Orthopedic
6.2.4.1. Absolute $ Opportunity
6.2.4.2. Market Value Forecast, By Region
6.2.5. CNS disease treatment
6.2.5.1. Absolute $ Opportunity
6.2.5.2. Market Value Forecast, By Region
6.2.6. Others
6.2.6.1. Absolute $ Opportunity
6.2.6.2. Market Value Forecast, By Region
6.3. Market Attractiveness Analysis, By Application
6.4. Prominent Trends

7. Global Regenerative Therapies Market Analysis, By End User
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison, By End User
7.1.2. Market Share & Basis Point (BPS) Analysis, By End User
7.2. Market Forecast, By End User
7.2.1. Hospitals
7.2.1.1. Absolute $ Opportunity
7.2.1.2. Market Value Forecast, By Region
7.2.2. Ambulatory Surgical Centers
7.2.2.1. Absolute $ Opportunity
7.2.2.2. Market Value Forecast, By Region
7.2.3. Educational Institutes
7.2.3.1. Absolute $ Opportunity
7.2.3.2. Market Value Forecast, By Region
7.3. Market Attractiveness Analysis, By End User
7.4. Prominent Trends

8. Global Regenerative Therapies Market Analysis, By Region
8.1. Introduction
8.1.1. Y-o-Y Growth Projections, By Region
8.1.2. Market Share & Basis Point (BPS) Analysis, By Region
8.2. Market Forecast, By Region
8.2.1. North America Market Value Forecast
8.2.2. Latin America Market Value Forecast
8.2.3. Europe Market Value Forecast
8.2.4. Asia Pacific Market Value Forecast
8.2.5. MEA Market Value Forecast
8.3. Regional Attractiveness Analysis

9. North America Regenerative Therapies Market Analysis
9.1. Introduction
9.1.1. Y-o-Y Growth Projections, By Country
9.1.2. Market Share & Basis Point (BPS) Analysis, By Country
9.1.3. Key Regulations
9.1.4. Key Trends
9.2. North America Market Forecast
9.2.1. Market Value Forecast, By Country
9.2.1.1. US Absolute $ Opportunity
9.2.1.2. Canada Absolute $ Opportunity
9.3. Market Value Forecast, By Tissue Type
9.3.1. Allograft
9.3.2. Xenograft
9.3.3. Alloplast
9.4. Market Value Forecast, By Application
9.4.1. Soft Tissue Repair
9.4.2. Cardiovascular
9.4.3. Dental
9.4.4. Orthopedic
9.4.5. CNS disease treatment
9.4.6. Others
9.5. Market Value Forecast, By End User
9.5.1. Hospitals
9.5.2. Ambulatory Surgical Centers
9.5.3. Educational Institutes
9.6. Market Attractiveness Analysis
9.6.1. By Country
9.6.2. By Tissue Type
9.6.3. By Application
9.6.4. By End User
9.7. Drivers & Restraints: Impact Analysis

10.1. Introduction
10.1.1. Y-o-Y Growth Projections, By Country
10.1.2. Market Share & Basis Point (BPS) Analysis, By Country
10.1.3. Key Regulations
10.1.4. Key Trends
10.2. Latin America Market Forecast
10.2.1. Market Value Forecast, By Country
10.2.1.1. Brazil Absolute $ Opportunity
10.2.1.2. Mexico Absolute $ Opportunity
10.2.1.3. Rest of Latin America Absolute $ Opportunity
10.3. Market Value Forecast, By Tissue Type
10.3.1. Allograft
10.3.2. Xenograft
10.3.3. Alloplast
10.4. Market Value Forecast, By Application
10.4.1. Soft Tissue Repair
10.4.2. Cardiovascular
10.4.3. Dental
10.4.4. Orthopedic
10.4.5. CNS disease treatment
10.4.6. Others
10.5. Market Value Forecast, By End User
10.5.1. Hospitals
10.5.2. Ambulatory Surgical Centers
10.5.3. Educational Institutes
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Tissue Type
10.6.3. By Application
10.6.4. By End User
10.7. Drivers & Restraints: Impact Analysis

11. Europe Regenerative Therapies Market Analysis
11.1. Introduction
11.1.1. Y-o-Y Growth Projections, By Country / Region
11.1.2. Market Share & Basis Point (BPS) Analysis, By Country / Region
11.1.3. Key Regulations
11.1.4. Key Trends
11.2. Europe Market Forecast
11.2.1. Market Value Forecast, By Country/Region
11.2.1.1. Germany Absolute $ Opportunity
11.2.1.2. United Kingdom Absolute $ Opportunity
11.2.1.3. France Absolute $ Opportunity
11.2.1.4. Rest of Western Europe Absolute $ Opportunity
11.3. Market Value Forecast, By Tissue Type
11.3.1. Allograft
11.3.2. Xenograft
11.3.3. Alloplast
11.4. Market Value Forecast, By Application
11.4.1. Soft Tissue Repair
11.4.2. Cardiovascular
11.4.3. Dental
11.4.4. Orthopedic
11.4.5. CNS disease treatment
11.4.6. Others
11.5. Market Value Forecast, By End User
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Educational Institutes
11.6. Market Attractiveness Analysis
11.6.1. By Country
11.6.2. By Tissue Type
11.6.3. By Application
11.6.4. By End User
11.7. Drivers & Restraints: Impact Analysis

12. Asia Pacific Regenerative Therapies Market Analysis
12.1. Introduction
12.1.1. Y-o-Y Growth Projections, By Country
12.1.2. Market Share & Basis Point (BPS) Analysis, By Country / Region
12.1.3. Key Regulations
12.1.4. Key Trends
12.2. Asia Pacific Market Forecast
12.2.1. Market Value Forecast, By Country/Region
12.2.1.1. Greater China Absolute $ Opportunity
12.2.1.2. India Absolute $ Opportunity
12.2.1.3. Japan Absolute $ Opportunity
12.2.1.4. Singapore Absolute $ Opportunity
12.2.1.5. Australia and New Zealand Absolute $ Opportunity
12.2.1.6. Rest of APAC Absolute $ Opportunity
12.3. Market Value Forecast, By Tissue Type
12.3.1. Allograft
12.3.2. Xenograft
12.3.3. Alloplast
12.4. Market Value Forecast, By Application
12.4.1. Soft Tissue Repair
12.4.2. Cardiovascular
12.4.3. Dental
12.4.4. Orthopedic
12.4.5. CNS disease treatment
12.4.6. Others
12.5. Market Value Forecast, By End User
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Educational Institutes
12.6. Market Attractiveness Analysis
12.6.1. By Country
12.6.2. By Tissue Type
12.6.3. By Application
12.6.4. By End User
12.7. Drivers & Restraints: Impact Analysis

13. MEA Regenerative Therapies Market Analysis
13.1. Introduction
13.1.1. Y-o-Y Growth Projections, By Country / Region
13.1.2. Market Share & Basis Point (BPS) Analysis, By Country / Region
13.1.3. Key Regulations
13.1.4. Key Trends
13.2. MEA Market Forecast
13.2.1. Market Value Forecast, By Country/Region
13.2.1.1. GCC Absolute $ Opportunity
13.2.1.2. South Africa Absolute $ Opportunity
13.2.1.3. Rest of MEA Absolute $ Opportunity
13.3. Market Value Forecast, By Tissue Type
13.3.1. Allograft
13.3.2. Xenograft
13.3.3. Alloplast
13.4. Market Value Forecast, By Application
13.4.1. Soft Tissue Repair
13.4.2. Cardiovascular
13.4.3. Dental
13.4.4. Orthopedic
13.4.5. CNS disease treatment
13.4.6. Others
13.5. Market Value Forecast, By End User
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Educational Institutes
13.6. Market Attractiveness Analysis
13.6.1. By Country
13.6.2. By Tissue Type
13.6.3. By Application
13.6.4. By End User
13.7. Drivers & Restraints: Impact Analysis

14.1. Competition Dashboard
14.2. Company Profiles
14.2.1. Revenue
14.2.2. Products/Brand Offerings
14.2.3. Key developments
14.2.4. SWOT Analysis
14.3. Company Highlights
14.3.1. Shire Pharmaceuticals
14.3.2. Kinetic Concepts, Inc.
14.3.3. Mesoblast Ltd.
14.3.4. Cytomedix Inc.
14.3.5. Advanced Cell Technology, Inc.
14.3.6. Organovo Holdings Inc.
14.3.7. Orgenesis Inc.
14.3.8. Genzyme
14.3.9. Athersys, Inc.
14.3.10.Cytori Therapeutics, Inc.

List of Table

Table 01: Global Regenerative Therapies Market Value, by Tissue Type, 20102022 (US$ Mn)
Table 02: Global Regenerative Therapies Market Value, by Application, 20102022 (US$ Mn)
Table 03: Global Regenerative Therapies Market Value, by End User, 20102022 (US$ Mn)
Table 04: Global Regenerative Therapies Market Value, by Region, 20102022 (US$ Mn)
Table 05: North America Regenerative Therapies Market Value, by Application, 20102022 (US$ Mn)
Table 06: North America Regenerative Therapies Market Value, by End User, 20102022 (US$ Mn)
Table 07: Latin America Regenerative Therapies Market Value, by Application, 20102022 (US$ Mn)
Table 08: Latin America Regenerative Therapies Market Value, by End User, 20102022 (US$ Mn)
Table 09: Europe Regenerative Therapies Market Value, by Application, 20102022 (US$ Mn)
Table 10: Europe Regenerative Therapies Market Value, by End User, 20102022 (US$ Mn)
Table 11: APAC Regenerative Therapies Market Value, by Application, 20102022 (US$ Mn)
Table 12: APAC Regenerative Therapies Market Value, by End User, 20102022 (US$ Mn)
Table 13: MEA Regenerative Therapies Market Value, by Application, 20102022 (US$ Mn)
Table 14: APAC Regenerative Therapies Market Value, by End User, 20102022 (US$ Mn)

List of Chart

Figure 1: Global Regenerative Therapies Market Value Share & BPS Analysis, by Tissue Type, 2011, 2015 & 2022
Figure 2: Global Regenerative Therapies Market Y-o-Y Growth Comparison, by Tissue Type, 2011 2022
Figure 3: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allografts Tissue type, 2010 2022
Figure 4: Global Regenerative Therapies Market Absolute $ Opportunity, by Allografts Tissue type, 2010 2022
Figure 5: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenografts, 2010 2022
Figure 6: Global Regenerative Therapies Market Absolute $ Opportunity, by Xenografts, 2010 2022
Figure 7: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast, 2010 2022
Figure 8: Global Regenerative Therapies Market Absolute $ Opportunity, by Alloplast, 2010 2022
Figure 9: Global Regenerative Therapies Market Attractiveness Analysis, by Tissue Type, 2015 2022
Figure 10: Global Regenerative Therapies Market Value Share & BPS Analysis, by Application, 2011, 2015 & 2022
Figure 11: Global Regenerative Therapies Market Y-o-Y Growth Comparison, by Application, 2011 2022
Figure 12: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Soft Tissue Repair, 2010 2022
Figure 13: Global Regenerative Therapies Market Absolute $ Opportunity, by Soft Tissue Repair, 2010 2022
Figure 14: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Cardiovascular, 2010 2022
Figure 15: Global Regenerative Therapies Market Absolute $ Opportunity, by Cardiovascular, 2010 2022
Figure 16: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Dental, 2015 2022
Figure 17: Global Regenerative Therapies Market Absolute $ Opportunity, by Dental, 2010 2022
Figure 18: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Orthopedic , 2010 2022
Figure 19: Global Regenerative Therapies Market Absolute $ Opportunity, by Orthopedic, 2010 2022
Figure 20: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by CNS disease treatment , 2010 2022
Figure 21: Global Regenerative Therapies Market Absolute $ Opportunity, by CNS disease treatment, 2015 2022
Figure 22: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Others, 2010 2022
Figure 23: Global Regenerative Therapies Market Absolute $ Opportunity, by Others , 2010 2022
Figure 24: Global Regenerative Therapies Market Attractiveness Analysis, by Application, 2015 2022
Figure 25: Global Regenerative Therapies Market Value Share & BPS Analysis, by End User, 2011, 2015 & 2022
Figure 26: Global Regenerative Therapies Market Y-o-Y Growth Comparison, by End User, 2011 2022
Figure 27: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Hospital Pharmacies, 2010 2022
Figure 28: Global Regenerative Therapies Market Absolute $ Opportunity, by Hospital Pharmacies, 2010 2022
Figure 29: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2010 2022
Figure 30: Global Regenerative Therapies Market Absolute $ Opportunity, by Ambulatory Surgical Centers, 2010 2022
Figure 31: Global Regenerative Therapies Market Value & Y-o-Y Growth (%), by Educational Institutes, 2010 2022
Figure 32: Global Regenerative Therapies Market Absolute $ Opportunity, by Educational Institutes, 2010 2022
Figure 33: Global Regenerative Therapies Market Attractiveness Analysis, by End User, 2015 2022
Figure 34: Global Regenerative Therapies Market Value Share & BPS Analysis, by Region, 2015 & 2022
Figure 35: Global Regenerative Therapies Market Y-o-Y Growth Comparison, by Region, 2015 2022
Figure 36: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), 2010 2022
Figure 37: North America Regenerative Therapies Market Absolute $ Opportunity, 2010 2022
Figure 38: Latin America Regenerative Therapies Market Value & Y-o-Y Growth (%), 2010 2022
Figure 39: Latin America Regenerative Therapies Market Absolute $ Opportunity, 2010 2022
Figure 40: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), 2010 2022
Figure 41: Europe Regenerative Therapies Market Absolute $ Opportunity, 2010 2022
Figure 42: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), 2010 2022
Figure 43: APAC Regenerative Therapies Market Absolute $ Opportunity, 2010 2022
Figure 44: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), 2010 2022
Figure 45: MEA Regenerative Therapies Market Absolute $ Opportunity, 2010 2022
Figure 46: Global Regenerative Therapies Market Attractiveness Analysis, by Region, 2015 2022
Figure 47: North America Regenerative Therapies Market Value Share & BPS Analysis, by Country, 2015 & 2022
Figure 48: North America Regenerative Therapies Market Y-o-Y Growth Comparison, by Country, 2015 2022
Figure 49: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by the U.S., 2010 2022
Figure 50: North America Regenerative Therapies Market Absolute $ Opportunity, by the U.S., 2010 2022
Figure 51: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Canada, 2010 2022
Figure 52: North America Regenerative Therapies Market Absolute $ Opportunity, by Canada, 2010 2022
Figure 53: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allograft tissue type segment, 2010 2022
Figure 54: North America Regenerative Therapies Market Absolute $ Opportunity, by Allograft tissue type segment, 2010 2022
Figure 55: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenograft tissue type segment, 2010 2022
Figure 56: North America Regenerative Therapies Market Absolute $ Opportunity, by Xenograft tissue type segment, 2010 2022
Figure 57: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast tissue type segment, 2010 2022
Figure 58: North America Regenerative Therapies Market Absolute $ Opportunity, by Alloplast tissue type segment, 2010 2022
Figure 59: North America Regenerative Therapies Market Attractiveness Analysis, by Country, 2015 2022
Figure 60: North America Regenerative Therapies Market Attractiveness Analysis, by Application, 2015 2022
Figure 61: North America Regenerative Therapies Market Attractiveness Analysis, by End User, 2015 2022
Figure 62: Latin America Regenerative Therapies Market Value Share & BPS Analysis, by Country, 2015 & 2022
Figure 63: Latin America Regenerative Therapies Market Y-o-Y Growth Comparison, by Country, 2011 2022
Figure 64: Latin America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Brazil, 2010 2022
Figure 65: Latin America Regenerative Therapies Market Absolute $ Opportunity, by Brazil, 2010 2022
Figure 66: Latin America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Mexico, 2010 2022
Figure 67: Latin America Regenerative Therapies Market Absolute $ Opportunity, by Mexico, 2010 2022
Figure 68: Latin America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Rest of Latin America, 2010 2022
Figure 69: Latin America Regenerative Therapies Market Absolute $ Opportunity, by Rest of Latin America, 2010 2022
Figure 70: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allograft tissue type segment, 2015 2022
Figure 71: North America Regenerative Therapies Market Absolute $ Opportunity, by Allograft tissue type segment, 2010 2022
Figure 72: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenograft tissue type segment, 2015 2022
Figure 73: North America Regenerative Therapies Market Absolute $ Opportunity, by Xenograft tissue type segment, 2010 2022
Figure 74: North America Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast tissue type segment, 2015 2022
Figure 75: North America Regenerative Therapies Market Absolute $ Opportunity, by Alloplast tissue type segment, 2010 2022
Figure 76: Latin America Regenerative Therapies Market Attractiveness Analysis, by Country, 2015 2022
Figure 77: Latin America Regenerative Therapies Market Attractiveness Analysis, by Tissue Type, 2015 2022
Figure 78: Latin America Regenerative Therapies Market Attractiveness Analysis, by Application, 2015 2022
Figure 79: Latin America Regenerative Therapies Market Attractiveness Analysis, by End User, 2015 2022
Figure 80: Europe Regenerative Therapies Market Value Share & BPS Analysis, by Country, 2011, 2015 & 2022
Figure 81: Europe Regenerative Therapies Market Y-o-Y Growth Comparison, by Country, 2011 2022
Figure 82: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Germany, 2010 2022
Figure 83: Europe Regenerative Therapies Market Absolute $ Opportunity, by Germany, 2010 2022
Figure 84: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by U.K., 2010 2022
Figure 85: Europe Regenerative Therapies Market Absolute $ Opportunity, by U.K., 2010 2022
Figure 86: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by France, 2010 2022
Figure 87: Europe Regenerative Therapies Market Absolute $ Opportunity, by France, 2010 2022
Figure 88: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Spain, 2010 2022
Figure 89: Europe Regenerative Therapies Market Absolute $ Opportunity, by Spain, 2010 2022
Figure 90: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Italy, 2010 2022
Figure 91: Europe Regenerative Therapies Market Absolute $ Opportunity, by Italy, 2010 2022
Figure 92: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Russia, 2010 2022
Figure 93: Europe Regenerative Therapies Market Absolute $ Opportunity, by Russia, 2010 2022
Figure 94: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Rest of Europe, 2010 2022
Figure 95: Europe Regenerative Therapies Market Absolute $ Opportunity, by Rest of Europe, 2010 2022
Figure 96: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allograft tissue type segment, 2010 2022
Figure 97: Europe Regenerative Therapies Market Absolute $ Opportunity, by Allograft tissue type segment, 2010 2022
Figure 98: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenograft tissue type segment, 2010 2022
Figure 99: Europe Regenerative Therapies Market Absolute $ Opportunity, by Xenograft tissue type segment, 2010 2022
Figure 100: Europe Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast tissue type segment, 2010 2022
Figure 101: Europe Regenerative Therapies Market Absolute $ Opportunity, by Alloplast tissue type segment, 2010 2022
Figure 102: Europe Regenerative Therapies Market Attractiveness Analysis, by Country, 2015 2022
Figure 103: Europe Regenerative Therapies Market Attractiveness Analysis, by Tissue Type, 2015 2022
Figure 104: Europe Regenerative Therapies Market Attractiveness Analysis, by Application, 2015 2022
Figure 105: Europe Regenerative Therapies Market Attractiveness Analysis, by End User, 2015 2022
Figure 106: APAC Regenerative Therapies Market Value Share & BPS Analysis, by Country, 2011, 2015 & 2022
Figure 107: APAC Regenerative Therapies Market Y-o-Y Growth Comparison, by Country, 2011 2022
Figure 108: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Greater China, 2010 2022
Figure 109: APAC Regenerative Therapies Market Absolute $ Opportunity, by Greater China, 2010 2022
Figure 110: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by India, 2010 2022
Figure 111: APAC Regenerative Therapies Market Absolute $ Opportunity, by India, 2010 2022
Figure 112: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Japan, 2010 2022
Figure 113: APAC Regenerative Therapies Market Absolute $ Opportunity, by Japan, 2010 2022
Figure 114: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Singapore, 2010 2022
Figure 115: APAC Regenerative Therapies Market Absolute $ Opportunity, by Singapore, 2010 2022
Figure 116: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Australia & New Zealand , 2010 2022
Figure 117: APAC Regenerative Therapies Market Absolute $ Opportunity, by Australia & New Zealand , 2010 2022
Figure 118: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Taiwan, 2010 2022
Figure 119: APAC Regenerative Therapies Market Absolute $ Opportunity, by Taiwan, 2010 2022
Figure 120: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by South Korea, 2010 2022
Figure 121: APAC Regenerative Therapies Market Absolute $ Opportunity, by South Korea, 2010 2022
Figure 122: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Rest of APAC, 2010 2022
Figure 123: APAC Regenerative Therapies Market Absolute $ Opportunity, by Rest of APAC, 2010 2022
Figure 124: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allograft tissue type segment, 2010 2022
Figure 125: APAC Regenerative Therapies Market Absolute $ Opportunity, by Allograft tissue type segment, 2010 2022
Figure 126: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenograft tissue type segment, 2010 2022
Figure 127: APAC Regenerative Therapies Market Absolute $ Opportunity, by Xenograft tissue type segment, 2010 2022
Figure 128: APAC Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast tissue type segment, 2010 2022
Figure 129: APAC Regenerative Therapies Market Absolute $ Opportunity, by Alloplast tissue type segment, 2010 2022
Figure 130: APAC Regenerative Therapies Market Attractiveness Analysis, by Country, 2015 2022
Figure 131: APAC Regenerative Therapies Market Attractiveness Analysis, by Tissue Type, 2015 2022
Figure 132: APAC Regenerative Therapies Market Attractiveness Analysis, by Application, 2015 2022
Figure 133: APAC Regenerative Therapies Market Attractiveness Analysis, by End User, 2015 2022
Figure 134: MEA Regenerative Therapies Market Value Share & BPS Analysis, by Country, 2015 & 2022
Figure 135: MEA Regenerative Therapies Market Y-o-Y Growth Comparison, by Country, 2015 2022
Figure 136: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by GCC countries, 2010 2022
Figure 137: MEA Regenerative Therapies Market Absolute $ Opportunity, by GCC countries, 2010 2022
Figure 138: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by S. Africa, 2010 2022
Figure 139: MEA Regenerative Therapies Market Absolute $ Opportunity, by S. Africa, 2010 2022
Figure 140: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by Rest of MEA, 2010 2022
Figure 141: MEA Regenerative Therapies Market Absolute $ Opportunity, by Rest of MEA, 2010 2022
Figure 142: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by Allograft tissue type segment, 2010 2022
Figure 143: MEA Regenerative Therapies Market Absolute $ Opportunity, by Allograft tissue type segment, 2010 2022
Figure 144: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by Xenograft tissue type segment, 2010 2022
Figure 145: MEA Regenerative Therapies Market Absolute $ Opportunity, by Xenograft tissue type segment, 2010 2022
Figure 146: MEA Regenerative Therapies Market Value & Y-o-Y Growth (%), by Alloplast tissue type segment, 2010 2022
Figure 147: MEA Regenerative Therapies Market Absolute $ Opportunity, by Alloplast tissue type segment, 2010 2022
Figure 148: MEA Regenerative Therapies Market Attractiveness Analysis, by Country, 2015 2022
Figure 149: MEA Regenerative Therapies Market Attractiveness Analysis, by Tissue Type, 2015 2022
Figure 150: MEA Regenerative Therapies Market Attractiveness Analysis, by Application, 2015 2022
Figure 151: MEA Regenerative Therapies Market Attractiveness Analysis, by End User, 2015 2022

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *